BackPersonalis Overview
Personalis Inc

Personalis Target Price

Where could PSNL trade next? Consensus target price: $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.21

Average Target Price

$13.902.2% downside

5 analysts in the last 4 months

High: $17 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-21BTIG$16.2514.4% upsideOpen
2026-07-20Lake StreetThomas Flaten$16.2514.4% upsideOpen
2026-07-17Needham$1719.6% upsideOpen
2026-05-12Morgan Stanley$936.7% downsideOpen
2026-05-11BTIGMark Massaro$1122.6% downsideOpen
2026-01-26GuggenheimSubbu Nambi$138.5% downsideOpen
2025-12-01Morgan StanleyKallum Titchmarsh$1122.6% downsideOpen
2025-11-05Lake StreetThomas Flaten$1122.6% downsideOpen
2025-11-05NeedhamMike Matson$1029.6% downsideOpen
2025-08-06BTIGMark Massaro$657.8% downsideOpen
2024-08-19Lake StreetThomas Flaten$843.7% downsideOpen
2024-08-19H.C. WainwrightSwayampakula Ramakanth$936.7% downsideOpen
2024-08-16BTIGMark Massaro$750.7% downsideOpen
2024-08-08BTIGMark Massaro$5.561.3% downsideOpen
2024-08-08NeedhamMike Matson$5.561.3% downsideOpen
2024-06-21NeedhamMike Matson$3.575.4% downsideOpen
2024-04-30Loop Capital MarketsThomas Flaten$471.9% downsideOpen
2022-05-06Morgan Stanley$138.5% downsideOpen

Personalis (PSNL) FAQ

Personalis's target price stands at $14. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $14 for PSNL implies 2.2% downside versus today's price ($14.21). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Personalis's target price evolved across reporting periods, while the comparison chart places PSNL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Personalis's reading of $14 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.